Education
About Us
Working with TipRanks
Follow Us
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
RESEARCH TOOLSreports
Total Valuation
Neuroscientific Biopharmaceuticals Ltd. has a market cap or net worth of AU$9.69M. The enterprise value is AU$5.76M.
Market CapAU$9.69M
Enterprise ValueAU$5.76M
Share Statistics
Neuroscientific Biopharmaceuticals Ltd. has 144,604,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding144,604,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neuroscientific Biopharmaceuticals Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 6.60%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)6.60%
Return on Capital Employed (ROCE)-0.38
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.42
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Neuroscientific Biopharmaceuticals Ltd. is 18.18. Neuroscientific Biopharmaceuticals Ltd.’s PEG ratio is 0.27.
PE Ratio18.18
PS Ratio0.00
PB Ratio2.05
Price to Fair Value1.10
Price to FCF-7.27
Price to Operating Cash Flow-7.37
PEG Ratio0.27
Income Statement
In the last 12 months, Neuroscientific Biopharmaceuticals Ltd. had revenue of 2.28M and earned 324.21K in profits. Earnings per share was 0.00.
Revenue2.28M
Gross Profit2.19M
Operating Income-2.06M
Pretax Income-1.89M
Net Income324.21K
EBITDA-1.80M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 1.16M and capital expenditures 0.00, giving a free cash flow of 1.16M billion.
Operating Cash Flow1.16M
Free Cash Flow1.16M
Free Cash Flow per Share<0.01
Dividends & Yields
Neuroscientific Biopharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.11
52-Week Price Change75.00%
50-Day Moving Average0.05
200-Day Moving Average0.04
Relative Strength Index (RSI)69.14
Average Volume (3m)150.25K
Important Dates
Neuroscientific Biopharmaceuticals Ltd. upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 26, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Neuroscientific Biopharmaceuticals Ltd. as a current ratio of 58.87, with Debt / Equity ratio of 0.00%
Current Ratio58.87
Quick Ratio58.87
Debt to Market Cap0.00
Net Debt to EBITDA2.76
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Neuroscientific Biopharmaceuticals Ltd. has paid -2.21M in taxes.
Income Tax-2.21M
Effective Tax Rate1.17
Enterprise Valuation
Neuroscientific Biopharmaceuticals Ltd. EV to EBITDA ratio is -0.52, with an EV/FCF ratio of 22.17.
EV to Sales0.41
EV to EBITDA-0.52
EV to Free Cash Flow22.17
EV to Operating Cash Flow21.26
Balance Sheet
Neuroscientific Biopharmaceuticals Ltd. has AU$4.49M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$4.49M billion.
Cash & Marketable SecuritiesAU$4.49M
Total DebtAU$0.00
Net Cash-AU$4.49M
Net Cash Per Share-AU$0.03
Tangible Book Value Per ShareAU$0.03
Margins
Gross margin is -63.09%, with operating margin of -90.24%, and net profit margin of 14.23%.
Gross Margin-63.09%
Operating Margin-90.24%
Pretax Margin-82.83%
Net Profit Margin14.23%
EBITDA Margin-78.82%
EBIT Margin-82.83%
Analyst Forecast
The average price target for Neuroscientific Biopharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast51.85%